Evidence map›Paper›PMID 35964061›Full record

Trial reportTrials2022

Fostering shared decision-making about prostate cancer screening among African American men patients and their primary care providers: a randomized behavioral clinical trial.

Margarita Echeverri, Kyazia Felder, David Anderson, Elora Apantaku, Patrick Leung, Clare Hoff, Princess Dennar

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Margarita EcheverriEducational Coordinator Health Disparities, Diversity and Cultural Competence; Center of Minority Health and Health Disparities Research and Education, Xavier University of Louisiana; College of Pharmacy, 1 Drexel Drive, New Orleans, LA, 70125, USA. mechever@xula.edu.ORCID http://orcid.org/0000-0002-8003-5355
Kyazia FelderDepartment of Clinical and Administrative Sciences, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA, 70125, USA.
David AndersonDepartment of Mathematics, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA, 70125, USA.
Elora ApantakuPreventive Medicine Residency PGY2, Tulane University, School of Medicine, 131 S. Robertson St, 11th Floor, New Orleans, LA, 70112, USA.
Patrick LeungMedical Physicians Group PLLC, 11555 Central Parkway, Suite 903, Jacksonville, FL, 32224, USA.
Clare HoffDepartment of Family and Community Medicine, Tulane University School of Medicine, 131 S. Robertson St, 11th Floor, New Orleans, LA, 70112, USA.
Princess DennarPremium Care Medical Center, LLC, 3570 Holiday Drive, Suites 3-7, New Orleans, LA, 70114, USA.
Xavier University of Louisiana · USTulane University · USArk Medical Center · USUniversity of Holy Cross · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
Xavier RCMI Renewal Application-Research Infrastructure CoreU54MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI Thomas Wiese · 2019 to 2026
$41.9M
Xavier Pharmacy Endowment For Minority HealthS21MD000100 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI FRANCIS, NORMAN C. · 2001 to 2011
$39.0M
NIGMS NIH HHS U54 GM104940NIGMS NIH HHS U54GM104940NIMHD NIH HHS S21MD0000100NIMHD NIH HHS S21 MD000100NIMHD NIH HHS U54 MD007595NIMHD NIH HHS U54MD007595-5956
6 · The paper itself

Abstract

backgroundProstate cancer is the third most prevalent cancer in the American population. Furthermore, the prognosis is worse in African American as there is increased morbidity and mortality associated with it. PURPOSE: The purpose of this study is to evaluate the effectiveness of a new online method to educate the patient population regarding prostate cancer risk, diagnosis, treatments, and their decisions about whether to be screened for the early detection of prostate cancer.

methodsTwo hundred Black male patients are recruited from different clinical sites and randomized to either the control arm (usual care) or the intervention arm (educational program). We will compare the effectiveness of the intervention to see if patients are discussing the need of getting a prostate-specific antigen (PSA) test, and the possible benefits and harms that may result of having or not having the test, with their primary care providers. DISCUSSION: Shared decision-making (SDM) is the current standard in most cancer-screening guidelines and also a standard of person-centered care. However, there is a lack of evidence-based approaches to improve decision quality in clinical settings and an increased ambiguity of applying SDM for PSA-based screening among Black men in primary care. Our proposal to evaluate a decisional-aid intervention and measure the actual application of SDM during clinical encounters has a high potential to advance the translation path of implementing shared decision-making in clinical settings and provide evidence of the applicability of the guideline in general. INNOVATION AND OVERALL IMPACT: Given the 2018 USPSTF updated guidelines recommending shared decision-making about PSA-based screening, the increased risk of prostate cancer mortality in Black men, the challenges of evidence-based decision-making due to the underrepresentation of Blacks in major randomized clinical trials, and implicit racial bias among primary care providers, the time is ripe for interventions to improve shared decision-making about prostate cancer screening in Black men. In this study, we address communication and knowledge gaps between Black men and their primary care providers. The intervention, if proven effective, can be readily scaled across primary care practices across the U.S. and may be adapted to other types of cancer where guidelines have included shared decision-making as well. Early detection of prostate cancer may decrease mortality and morbidity in the long term.

Indexed as

Early Detection of CancerProstatic NeoplasmsBehaviorBlack or African AmericanDecision MakingHumansMalePrimary Health CareProstate-Specific AntigenUnited StatesProstate-Specific AntigenAfrican American menDecision aidPrimary care providersProstate cancerPSA screeningRandomized controlled trialShared decision-making

Identifiers

PMID35964061
PMCPMC9375278
OpenAlexW4291168536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.